Title: Identification and characterization of potential impurities of rabeprazole sodium.
Journal: Journal of pharmaceutical and biomedical analysis 20070312
131926-99-3
138530-95-7
151602-49-2
161796-78-7
103577-45-3
73590-58-6
1927-95-3 | 4-Bromophenyl acetate | AA007R3Y | MFCD00560954
194206-80-9 | 2-([(tert-Butoxy)carbonyl](2-methylpropyl)amino)acetic acid | AA007RN6 | MFCD17286086
18630-93-8 | 4-(Ethoxymethylene)isoquinoline-1,3(2H,4H)-dione | AA007S9P | MFCD08271808
1072944-35-4 | N-Cyclopropyl 4-bromo-3-methoxybenzamide | AA007T0I | MFCD11504870
1089687-03-5 | Dichlorobis(2-ethylhexyl)silane | AA007TPW | MFCD22370170
108586-21-6 | Ethyl 7-oxabicyclo[2.2.1]hept-2-ene-3-carboxylate | AA007UF2 | MFCD31556166
110448-35-6 | 5-Iodonaphthalene-1-sulfonyl chloride | AA007V1C | MFCD01863404
110105-98-1 | N-(3-Methylpyridin-2-yl)piperidine-4-carboxamide | AA007VP3 | MFCD11128699
1054-88-2 | Spiroxatrine (R 5188) | AA007WA6 | MFCD00055134
15180-47-9 | Ethanamine,N-ethyl-N-[(triethoxysilyl)methyl]- | AA007WR2 | MFCD01728991